Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1791 of 6351
-
Could a neck vein check replace a harder ultrasound for ICU fluid management?
Diagnosis CompletedAssessment of intravascular volume status is an important component of hemodynamic management in critically ill patients. Several noninvasive and minimally invasive parameters, including the pleth variability index (PVI), pulse pressure variation (PPV), stroke volume variation (S…
Sponsor: Gaziosmanpasa Research and Education Hospital • Aim: Diagnosis
Last updated Sep 09, 2026 23:00 UTC
-
New gel could halt tooth decay in preschoolers without drilling
Disease control OngoingThe objective is to determine whether the efficacy of a 38% silver diamine fluoride (SDF) gel is non-inferior to a 38% SDF solution for arresting carious lesions in preschool children when applied at half-yearly intervals over a 30-month period.
Phase 2 • Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New drug duo takes on Hard-to-Treat prostate cancer
Disease control Recruiting nowThis is a Phase 1/2, open-label, randomized, dose finding and dose expansion study to evaluate the safety, preliminary efficacy, and PK of gedatolisib in combination with darolutamide in subjects with mCRPC.
Phase 1/2 • Sponsor: Celcuity Inc • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Gut bacteria trial aims to slow ALS and dementia
Disease control Recruiting nowThe aim of this study is to assess the impact of a probiotic formulation on participants with ALS-FTDSD. It is hypothesized that participants given the probiotics will have different lipid profiles compared to participants receiving the placebo at different time points.
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Can team charters and handoff protocols boost school ADHD programs?
Disease control Recruiting nowThe proposed project aims to integrate team-based implementation strategies with an established school-based intervention for children with ADHD, the Collaborative Life Skills Program (CLS), to enhance its implementation and optimize its effectiveness. The investigators will tail…
Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Real-World study tests Mirikizumab's power against ulcerative colitis
Disease control CompletedThis is a real-life, multicenter, retrospective observational study with the aim to evaluate effectiveness and safety of Mirikizumab in a real life setting from the baseline up to manteinance at 12, 24 and 52 weeks. Patients with UC who have started mirikizumab will be included. …
Sponsor: IRCCS San Raffaele • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Breathing easy: dynamic x-rays may spot COPD faster and safer
Diagnosis Recruiting nowThe prevalence of chronic obstructive pulmonary disease (COPD) is on the rise, leading to an increasing economic and social burden. Currently, the diagnosis and staging of COPD heavily rely on pulmonary function testing. However, limitations such as patient cooperation and comorb…
Sponsor: Nanfang Hospital, Southern Medical University • Aim: Diagnosis
Last updated Jul 22, 2026 00:00 UTC
-
Stomach bug clues: can infection patterns forecast early cancer behavior?
Knowledge-focused Recruiting nowThis multicenter retrospective and prospective real-world observational study will evaluate the relationship of Helicobacter pylori (H. pylori) infection status, intragastric distribution, and pathological features with gastric cancer biological behavior and long-term prognosis i…
Sponsor: Chinese PLA General Hospital • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC
-
A pocket-sized coach for insulin users? app aims to boost self-care in type 2 diabetes
Disease control CompletedThe main purpose of the research is; To develop a mobile application for individuals with Type 2 diabetes who use insulin and to examine the effect of the developed mobile application on the perception and self-management of insulin use.
Sponsor: Ege University • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Pump iron, lift mood: study tests resistance training as depression treatment
Symptom relief Recruiting nowDepression is a leading cause of disability worldwide and current treatments are ineffective for many people. This trial will investigate the efficacy of a 16-week high vs low dose resistance exercise training program for the treatment of Major Depressive Disorder (MDD) in 200 ad…
Sponsor: University of Wisconsin, Madison • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
New heart Drug's secret powers revealed in small trial
Disease control OngoingVericiguat is a new drug that was recently approved by the Food and Drug Administration for patients with heart failure. In a large randomized controlled trial, this drug was found to help patients with heart failure live longer and stay out of the hospital more than normal treat…
Phase 4 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Heart artery showdown: shockwave or cutting balloon before stenting?
Disease control CompletedThe Short-Cut trial is a prospective, investigator-initiated, multicenter, randomized controlled trial that is designed to compare the efficacy of cutting balloon angioplasty vs. intravascular lithotripsy prior to drug-eluting stent implantation in patients with moderate to sever…
Sponsor: Baim Institute for Clinical Research • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Olive leaf extract put to the test against high blood pressure
Disease control CompletedThis study will be carried out in 2 emergency departments (at the exit of the emergency room) and 2 external consultations (endocrinology of the CHU FB Monastir and diabetology consultation, Jemmal hospital). Patients over 18 years of age with: Arterial hypertension (hypertensi…
Phase 2/3 • Sponsor: University of Monastir • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Can a special diet shape brain development in a rare epilepsy?
Knowledge-focused CompletedThis study aims to evaluate with the VINELAND II scale the long-term neurocognitive development of children above age 3 years with pyridoxine dependent epilepsy related to antiquitine deficiency.
Sponsor: University Hospital, Angers • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
New stroke drug shows promise in early trial
Disease control CompletedThis study is designed to determine the safety and efficacy of SHPL-49 intravenous infusion for 7 consecutive days in the treatment of acute ischemic stroke subjects.
Phase 2 • Sponsor: Shanghai Hutchison Pharmaceuticals Limited • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Gene therapy aims to stop bladder scarring in painful bladder condition
Disease control Recruiting nowTo evaluate the efficacy and safety of Neovasculgen in interstitial cystitis with Hunner's lesions to reduce cicatricial changes in the bladder caused by electrocoagulation and to prevent secondary bladder shrinkage with a decrease in its volume.
Phase 2/3 • Sponsor: JSC NextGen • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Nerve block shows promise for brain spasm after head injury
Disease control CompletedPosttraumatic Subarachnoid hemorrhage (SAH) is a life-threatening neurological problem with a high mortality rate. Delayed cerebral ischemia (DCI) is the second-leading cause of death and disability in patients suffering from SAH. DCI is strongly associated with cerebral arterial…
Sponsor: Assiut University • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New drug combo aims to shrink Hard-to-Treat tumors
Disease control Recruiting nowThis is a First-in-Human, Phase 1, Dose-Escalation and Dose-Expansion study of BH3120, as a single agent and in combination with pembrolizumab, to assess safety, tolerability, MTD, RP2D, PK, and efficacy in patients with advanced or metastatic solid tumors. Dose-Escalation part i…
Phase 1 • Sponsor: Hanmi Pharmaceutical Company Limited • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New drug aims to shield kidneys from dye damage during heart surgery
Disease control CompletedThis phase 2 study is to assess the safety and efficacy of APX-115 active doses in Contrast Induced Acute Kidney Disease compared to placebo following multiple oral dosing in patients with undergoing percutaneous coronary intervention. It is anticipated that approximately 230 pat…
Phase 2 • Sponsor: Aptabio Therapeutics, Inc. • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Plasma zaps HPV: new hope for cervical infections?
Disease control Recruiting nowThis is a prospective, single-center, observational proof-of-principle clinical trial at the Department of Women's Health of the University Hospital Tübingen.
Sponsor: University Hospital Tuebingen • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC